April 13, 2015

Arno Therapeutics Announces Three Poster Presentations at Upcoming AACR Annual Meeting 2015

April 10, 2015

Kite Pharma to Present at the 2015 Jefferies Immuno-Oncology Summit in Boston

April 8, 2015

Capricor Completes Enrollment of Initial Phase of DYNAMIC Clinical Trial of Cardiosphere-Derived Cell Therapy for Treatment of Advanced Heart Failure

April 6, 2015

Kite Pharma Announces Publication in Science of Cancer Immunotherapy Articles Authored by Lead Collaborators at the National Cancer Institute and the Netherlands Cancer Institute

March 31, 2015

Arno Therapeutics Reports Fourth Quarter 2014 Financial and Business Update

March 31, 2015

Capricor Therapeutics Completes Enrollment of Phase II Clinical Trial for Cenderitide to Treat Heart Failure

March 26, 2015

Kite Pharma Reports Full-Year and Fourth Quarter 2014 Financial Results

March 25, 2015

Kite Pharma to Report Fourth Quarter and Full Year 2014 Financial Results on March 26th, 2015

March 24, 2015

New Data Supporting Arno Therapeutics’ HDAC inhibitor AR-42 Published in The Journal of Urology

March 23, 2015

Capricor Therapeutics to Present at 3rd Annual Regen Med Investor Day on March 25, 2015 in New York

March 18, 2015

Capricor Therapeutics Reports Fourth Quarter and Full Year 2014 Financial & Business Highlights

March 17, 2015

Kite Pharma Strengthens Its T Cell Receptor (TCR) Cancer Gene Therapy Platform Through Acquisition of T-Cell Factory B.V. (TCF(TM))

March 12, 2015

Capricor Therapeutics to Hold Fourth Quarter 2014 Business Update Conference Call on March 18, 2015 at 4:30 p.m. EDT

March 10, 2015

Capricor Therapeutics to Present at the 27th Annual ROTH Conference

March 6, 2015

Kite Pharma to Present at the 2015 Barclays Global Healthcare Conference

March 5, 2015

Capricor Announces Enrollment of its Phase II Clinical Trial for Cenderitide to Treat Heart Failure

March 2, 2015

Kite Pharma Expands Its Research and Development Collaboration With the National Cancer Institute to Develop a Next Generation of Cancer Immunotherapy Products for Solid Tumors

February 23, 2015

Kite Pharma to Present at the Cowen and Company 35th Annual Health Care Conference

February 19, 2015

Kite Pharma Establishes Manufacturing Capabilities to Support Development and Commercialization of CAR and TCR Cancer Immunotherapy Products

February 3, 2015

Kite Pharma Expands and Strengthens Leadership Team

February 2, 2015

Kite Pharma to Present at the 17th Annual BIO CEO & Investor Conference

January 22, 2015

Kite Pharma Announces Expanded Agreement with Tel Aviv Sourasky Medical Center and Pioneering Researcher Professor Zelig Eshhar to Develop Novel Chimeric Antigen Receptor (CAR) Approaches for Cancer Immunotherapy

January 19, 2015

Kite Pharma Announces Presentations Highlighting Cancer Immunotherapy T Cell Manufacturing Process

January 12, 2015

Capricor Therapeutics Announces $10 Million Private Placement of Common Stock

January 12, 2015

Capricor Therapeutics Initiates the DYNAMIC Clinical Trial for the Treatment of Advanced Heart Failure